2018. Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S20. DOI:https://doi.org/10.25251/skin.2.supp.20.